That was a PR ploy. OMHE has never brought a single prescription med from incubation to human/animal trials to FDA approval to commercial/retail prescription sales.
There is ZERO evidence that any of the OMHE researchers have ever successfully developed a single prescription medication from incubation to market. Zero evidence.
Why would they PR the "fast track" buzzword? because no trader wants to hear that the average is closer to 12 years.
The time window of 3 years "fast track" buys OMHE insiders 3 years worth of time to compensate themselves.
So far, almost $1 mil compensated to insiders for the first two quarters of the current FY.
News 
Market Data 
Discover 
